Descemet's membrane substrate from human donor lens anterior capsule

Area of Science:

• Ophthalmology
• Tissue Engineering
• Cell Biology

Background:

• Descemet's membrane transplantation is a key treatment for corneal endothelial dysfunction.
• Current methods for obtaining endothelial cells for transplantation face limitations.

Purpose of the Study:

• To investigate the feasibility of using human donor anterior lens capsule as a substrate for culturing corneal endothelial cells.
• To evaluate the growth, morphology, and viability of endothelial cells cultured on this novel scaffold.

Main Methods:

• Anterior lens capsules from 30 donors were used as substrates.
• Human corneal endothelial cells were cultured on lens capsules, collagen membranes, and polystyrene plates.
• Cell density, morphology, adherence, and viability were assessed using microscopy and live-dead assays.
• Immunohistochemistry was performed to analyze protein expression.

Main Results:

• Anterior lens capsules provided a suitable substrate with a mean diameter of 10.05mm.
• Endothelial cell density on lens capsules was comparable to control groups.
• High cell viability (>95%) and monolayer growth with strong cell-cell interconnections were observed.
• Immunohistochemistry confirmed the expression of key endothelial cell markers.

Conclusions:

• Human donor anterior lens capsule serves as a viable scaffold for ex vivo expansion of human corneal endothelial cells.
• This finding suggests a potential alternative substrate for cell-based corneal therapies.
• Further research may optimize this approach for clinical applications.